Pfizer Animal Health Expands Into Aquaculture Health Market

Pfizer Animal Health has expanded its animal health activities into aquaculture with the acquisition of  Microtek International, Inc., a recognized innovator in aquaculture vaccines, R&D and healthcare diagnostic services.

"The time is right for Pfizer Animal Health to enter the global market for aquaculture healthcare therapeutics," said Juan Ramon Alaix, president, Pfizer Animal Health.  "The integration of Microtek R&D into Pfizer Animal Health also will allow us to build a more diverse and innovative portfolio in biopharmaceuticals.  The meat, dairy, egg and fish products that people enjoy for healthy living begin with a healthy food animal."

William Kay, Ph.D., president and chief executive officer, Microtek, who will continue to serve Pfizer in a consultant role, said, "Microtek not only brings to Pfizer Animal Health industry-leading vaccines and technology, but also complements Pfizer's portfolio of health services and diagnostics for food animal production."

Terms of Pfizer Animal Health's acquisition of Microtek were not disclosed.